Gooch & Housego PLC
10 August 2026
10 August 2026
Gooch & Housego PLC
('G&H' or the 'Company' or the 'Group')
Statement regarding AGM resolution voting
Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of optical components & systems, announces that following the voting outcomes at the Company's 2026 Annual General Meeting on 27 February 2026 on Resolutions 2 (Remuneration committee report - 53.9% against) and Resolution 12 (disapplication of pre-emption rights - 20.7% against), the Board has undertaken targeted engagement with shareholders to understand the reasons for the opposition to the Resolutions and is providing this update in accordance with Provision 4 of the UK Corporate Governance Code.
While the recommended cash acquisition for G&H announced on 16 July 2026 may limit the practical relevance of any future actions, the Board remains mindful of shareholder views and has carefully considered the feedback received.
- Ends -
For further information please contact:
|
Gooch & Housego PLC |
|
|
Charlie Peppiatt, Chief Executive Officer |
Tel: +44 (0) 1460 256 440 |
|
James Corte, Chief Financial Officer |
|
|
|
|
|
Burson Buchanan (Financial Communications) |
|
|
Henry Harrison-Topham, Sophie Wills and Abigail Gilchrist |
Tel: +44 (0) 20 7466 5000 |
|
|
|
|
Investec Bank plc (NOMAD and Broker) |
|
|
Christopher Baird, Carlton Nelson and Charles Craven |
Tel: +44 (0) 20 7597 5970 |
Notes to editors
Gooch & Housego is a photonics technology business with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace and Defence, Industrial and Telecom, and Life Sciences sectors. World-leading design, development and manufacturing expertise is offered across a broad range of complementary technologies. It is headquartered in Ilminster, Somerset, UK. For more information, please visit www.gandh.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.